Home/Filings/4/0001104659-23-107217
4//SEC Filing

PFREUNDSCHUH PETER P. 4

Accession 0001104659-23-107217

CIK 0001640266other

Filed

Oct 4, 8:00 PM ET

Accepted

Oct 5, 4:41 PM ET

Size

5.6 KB

Accession

0001104659-23-107217

Insider Transaction Report

Form 4
Period: 2023-10-03
PFREUNDSCHUH PETER P.
Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2023-10-03$6.99/sh13,567$94,833149,433 total
Footnotes (2)
  • [F1]Represents shares of common stock sold, pursuant to a durable automatic sales instruction letter effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations, in connection with the vesting of restricted stock units on October 1, 2023. The sales do not represent a discretionary trade by the reporting person.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.88 to $7.24, inclusive. The reporting person undertakes to provide to Voyager Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Issuer

Voyager Therapeutics, Inc.

CIK 0001640266

Entity typeother

Related Parties

1
  • filerCIK 0001585839

Filing Metadata

Form type
4
Filed
Oct 4, 8:00 PM ET
Accepted
Oct 5, 4:41 PM ET
Size
5.6 KB